Hiroshi Yamazaki
- Pharmacology top 0.01%
- Oncology top 0.2%
- Molecular Biology top 0.5%
- Cancer Research top 0.5%
- Biochemistry top 0.05%
- Co-authors
- Tsutomu ShimadaF. Peter GuengerichYukiharu InuiMayumi MimuraNorie MurayamaMakiko ShimizuYasuhiro UnoTsuyoshi Yokoi
- Topics
- Pharmacogenetics and Drug Metabolism (421 papers)Drug Transport and Resistance Mechanisms (243 papers)Carcinogens and Genotoxicity Assessment (66 papers)
- Cited by
- PharmacologyBiochemistryOncology
- Journals
- NatureProceedings of the National Academy of SciencesJournal of the American Chemical Society
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Hiroshi Yamazaki
839 papers receiving 21.6k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Pharmacology 11.8k
- Oncology 6.6k
- Molecular Biology 6.5k
- Cancer Research 2.1k
- Biochemistry 1.9k
Countries citing papers authored by Hiroshi Yamazaki
This map shows the geographic impact of Hiroshi Yamazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Yamazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Yamazaki more than expected).
Fields of papers citing papers by Hiroshi Yamazaki
This network shows the impact of papers produced by Hiroshi Yamazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Yamazaki. The network helps show where Hiroshi Yamazaki may publish in the future.
Co-authorship network of co-authors of Hiroshi Yamazaki
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Yamazaki. A scholar is included among the top collaborators of Hiroshi Yamazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Yamazaki. Hiroshi Yamazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 5 | |
| 11 | 10 | |
| 12 | 8 | |
| 13 | 28 | |
| 14 | 2 | |
| 15 | 21 | |
| 16 | 10 | |
| 17 | 3A-02 Effects of co-administration of food antioxidants and naturally occurring components, flavonoids on the activation of mutagens | 1 |
| 18 | Pharmacokinetics and tolerance of pantoprazole, a proton pump inhibitor after single and multiple oral doses in healthy Japanese volunteers. | 12 |
| 19 | 1 | |
| 20 | 2 |
About Hiroshi Yamazaki
Hiroshi Yamazaki is a scholar working on Pharmacology, Biochemistry and Oncology, having authored 871 papers that have together received 22.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (421 papers), Drug Transport and Resistance Mechanisms (243 papers) and Carcinogens and Genotoxicity Assessment (66 papers). The work is most often cited by research in Pharmacology (11.8k citations), Biochemistry (1.9k citations) and Oncology (6.6k citations). Hiroshi Yamazaki has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Tsutomu Shimada, F. Peter Guengerich, Yukiharu Inui, Mayumi Mimura, Norie Murayama, Makiko Shimizu, Yasuhiro Uno, Tsuyoshi Yokoi, Yune‐Fang Ueng and Kiyoshi Inoue. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.